SCHEMBL16633108

SCHEMBL16633108

Cc1ccc(S(=O)(=O)O)c(CCCNCCc2cccc(C#N)c2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN8A Q9UQD0 1/20 0.40
CNR1 P21554 1/20 0.39
IDH1 O75874 1/20 0.39
NOS1 P29475 1/20 0.38
TBXA2R P21731 2/20 0.37
NR3C1 P04150 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
KMT2A Q03164 2/20 0.35
FOLH1 Q04609 1/20 0.34
RAB9A P51151 1/20 0.34
MEN1 O00255 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
GAA P10253 1/20 0.34
PTPRB P23467 1/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC6 Q9UBN7 2/20 0.34
ADRB2 P07550 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
CHRM1 P11229 1/20 0.34
ADRA2B P18089 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16634084 0.92 SCN8A (0.50) SCN8ACNR1IDH1NOS1TBXA2R
SCHEMBL16633648 0.87 SCN8A (0.47) SCN8ACNR1IDH1NOS1TBXA2R
SCHEMBL16633107 0.80 TBXA2R (0.38) CNR1TBXA2RADRA2BADRA2CSLC6A2
SCHEMBL2964170 0.77 TBXA2R (0.40) IDH1NOS1TBXA2R
SCHEMBL18917603 0.77 TDP1 (0.40) TDP1KMT2ARAB9AMEN1TAAR1
SCHEMBL16634085 0.77 KCNN4 (0.35) IDH1TBXA2RSLC6A4
SCHEMBL16633106 0.75 GFER (0.45) TBXA2RTDP1KMT2AMEN1GAA
SCHEMBL16633649 0.74 KCNN4 (0.37) IDH1TBXA2R
SCHEMBL816601 0.72 GAA (0.39) TDP1KMT2AMEN1TAAR1GAA
SCHEMBL5718625 0.72 GAA (0.39) TDP1KMT2AMEN1TAAR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9238632-B2 3-cyanoanilinoalkylarylpiperazine derivative and use thereof in preparing drugs NHWA Pharma, Corporation (CN) 2016-01-19 US disclosed
US-20150105399-A1 3-CYANOANILINOALKYLARYLPIPERAZINE DERIVATIVE AND USE THEREOF IN PREPARING DRUGS SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105399-A1 3-CYANOANILINOALKYLARYLPIPERAZINE DERIVATIVE AND USE THEREOF IN PREPARING DRUGS HTR5A, HTR3C, HTR3A SCN8A 489/4885CNR1 48/4885IDH1 1998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.